ADVFN ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Qiagen NV

Qiagen NV (QGEN)

37,06
-0,36
( -0,96% )
Aktualisiert: 18:52:17

Qiagen NV (QGEN) Aktie

Echtzeit-Diskussionen und Handelsideen: Handeln Sie mit Zuversicht mit unserer leistungsstarken Plattform.

Premium

Wichtige Statistiken und Details

Current Price
37,06
( -0,96% )
Gebot
-
Fragen
-
Volumen
1.073.154
36,80 Tagesbereich 37,22
32,53 52-Wochen-Bereich 57,815
Marktkapitalisierung
Handelsende
37,42
Handelsbeginn
36,97
Letzte Trade
14
@
37.06
Letzter Handelszeitpunkt
18:52:24
Finanzvolumen
US$ 39.689.581
VWAP
36,9841
Durchschnittliches Volumen (3 Mio.)
US$ 2.092.154
Ausgegebene Aktien
206.800.618
Dividendenrendite (LTM)
0 (7,24%)
Kurs-Gewinn-Verhältnis
18,67
Gewinn pro Aktie (EPS)
1,94
Erlöse (LTM)
2,1B
Nettogewinn (LTM)
402,17M

Über Qiagen NV

Qiagen N.V. provides sample to insight solutions that transform biological samples into molecular insights worldwide. The company offers sample technology consumables, such as nucleic acid stabilization and purification kits for sample materials, manual and automated processing for genotyping, gene ... Qiagen N.V. provides sample to insight solutions that transform biological samples into molecular insights worldwide. The company offers sample technology consumables, such as nucleic acid stabilization and purification kits for sample materials, manual and automated processing for genotyping, gene expression, and viral and bacterial analysis, as well as silica membranes and magnetic bead technologies; secondary sample technology consumables, including kits and components for purification of nucleic acids; and instruments for nucleic acid purification, quality control, and accessories. It also provides Immune response consumables, such as interferon-gamma release assay for TB testing, and assays for post-transplant testing and viral load monitoring; oncology and sexual and reproductive health consumables, inclsuing assays for prenatal testing and detection of sexually transmitted diseases and HPV; assays for analysis of genomic variants; and sample to insight instruments, including one-step molecular analysis of hard-to-diagnose syndromes, and integrated PCR testing. The company offers research PCR consumables, such as quantitative PCR, reverse transcription, and combinations kits for analysis of gene expression, genotyping and gene regulation, and running on QIAGEN instruments and technologies; human ID/forensics assay consumables comprising short tandem repeat assays for human ID, and assays for food contamination; PCR instruments, including digital PCR and qPCR solutions; and developed and configured enzymes and PCR solutions. It offers NGS gene panels, library prep kits and components, and whole genome amplification; DNA methylation analysis; QIAGEN consumables and instruments; bioinformatics solutions; and sequence-based assays forensic genetic genealog services. it provides software-as-a-service. It serves molecular diagnostics and life sciences sectors. The company was founded in 1984 and is headquartered in Venlo, the Netherlands. Mehr anzeigen

Sektor
Healthcare
Branche
Biotechnology & Life Sciences
Website
Hauptsitz
Venlo, Netherlands
Gegründet
1984
Qiagen NV is listed in the Healthcare sector of the New York Börse with ticker QGEN. The last closing price for Qiagen NV was US$37,42. Over the last year, Qiagen NV shares have traded in a share price range of US$ 32,53 to US$ 57,815.

Qiagen NV currently has 206.800.618 shares in issue. The market capitalisation of Qiagen NV is US$7,66 billion. Qiagen NV has a price to earnings ratio (PE ratio) of 18.67.

QGEN Neueste Nachrichten

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
1-0.61-1.6193257233937.6737.8136.23203305237.11592495CS
43.811.425135297733.2638.132.91216228135.97731445CS
12-3.23-8.0168776371340.2942.3332.53206001336.57153349CS
26-7.96-17.68103065345.0257.81532.53220223343.73850445CS
52-9.92-21.115368241846.9857.81532.53175072345.02893282CS
156-8.64-18.905908096345.757.81532.53138036943.79493596CS
260-10.74-22.468619246947.85832.53116183145.04653841CS

QGEN - Frequently Asked Questions (FAQ)

What is the current Qiagen NV share price?
The current share price of Qiagen NV is US$ 37,06
How many Qiagen NV shares are in issue?
Qiagen NV has 206.800.618 shares in issue
What is the market cap of Qiagen NV?
The market capitalisation of Qiagen NV is USD 7,66B
What is the 1 year trading range for Qiagen NV share price?
Qiagen NV has traded in the range of US$ 32,53 to US$ 57,815 during the past year
What is the PE ratio of Qiagen NV?
The price to earnings ratio of Qiagen NV is 18,67
What is the cash to sales ratio of Qiagen NV?
The cash to sales ratio of Qiagen NV is 3,57
What is the registered address of Qiagen NV?
The registered address for Qiagen NV is Hulsterweg 82, Venlo, Limburg, 5912 PL
What is the Qiagen NV website address?
The website address for Qiagen NV is www.qiagen.com
Which industry sector does Qiagen NV operate in?
Qiagen NV operates in the Biotechnology & Life Sciences sector

QGEN Trades

Mehr

Trades verzögert

Um Echtzeit-Trades zu erhalten, aktualisieren Sie Ihr Konto

Auf Echtzeit aktualisieren
Keine Diskussionen Gefunden.
Neuen Thread Erstellen